Editas Medicine

Employees:
90
Market Cap:
$704.91 million
Revenue:
$6.03 million
Net Income:
$-101.62 million

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016. Wikipedia

Editas Medicine
Employees:
90
Market Cap:
$704.91 million
Revenue:
$6.03 million
Net Income:
$-101.62 million

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016. Wikipedia

5

Editas Medicine jobs